CSNK1A1
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
casein kinase 1 alpha 1 | MIM:600505 | Ensembl:ENSG00000113712 | HGNC:HGNC:2451 | PA26951 | 5q32 |
GO terms in CSNK1A1
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IEA | GO:0000902 | cell morphogenesis |
BP | IDA | GO:0006468 | protein phosphorylation |
BP | IMP | GO:0007030 | Golgi organization |
BP | IEA | GO:0007049 | cell cycle |
BP | NAS | GO:0007165 | signal transduction |
BP | TAS | GO:0007166 | cell surface receptor signaling pathway |
BP | IBA | GO:0016055 | Wnt signaling pathway |
BP | TAS | GO:0016055 | Wnt signaling pathway |
BP | IBA | GO:0018105 | peptidyl-serine phosphorylation |
BP | IDA | GO:0018105 | peptidyl-serine phosphorylation |
BP | IMP | GO:0018105 | peptidyl-serine phosphorylation |
BP | IMP | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
BP | IMP | GO:0045104 | intermediate filament cytoskeleton organization |
BP | IEA | GO:0051301 | cell division |
BP | IC | GO:0090090 | negative regulation of canonical Wnt signaling pathway |
BP | IMP | GO:0090090 | negative regulation of canonical Wnt signaling pathway |
BP | IMP | GO:1904424 | regulation of GTP binding |
BP | TAS | GO:1904885 | beta-catenin destruction complex assembly |
BP | TAS | GO:1904886 | beta-catenin destruction complex disassembly |
CC | IEA | GO:0000777 | condensed chromosome kinetochore |
CC | IBA | GO:0005634 | nucleus |
CC | IBA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005813 | centrosome |
CC | IDA | GO:0005829 | cytosol |
CC | TAS | GO:0005829 | cytosol |
CC | IDA | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex |
CC | TAS | GO:0005929 | cilium |
CC | HDA | GO:0016020 | membrane |
CC | IDA | GO:0016607 | nuclear speck |
CC | IDA | GO:0030877 | beta-catenin destruction complex |
CC | ISS | GO:0036064 | ciliary basal body |
CC | IDA | GO:0045095 | keratin filament |
CC | IEA | GO:1990904 | ribonucleoprotein complex |
MF | ISS | GO:0004672 | protein kinase activity |
MF | TAS | GO:0004672 | protein kinase activity |
MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
MF | IDA | GO:0004674 | protein serine/threonine kinase activity |
MF | IMP | GO:0004674 | protein serine/threonine kinase activity |
MF | TAS | GO:0004674 | protein serine/threonine kinase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | TAS | GO:0016301 | kinase activity |
Gene expression in normal tissue: CSNK1A1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CSNK1A1
Database | Pathway ID | Pathway Des. |
---|---|---|
pid | betacatenin_deg_pathway | Degradation of beta catenin |
pid | foxopathway | FoxO family signaling |
pid | hedgehog_glipathway | Hedgehog signaling events mediated by Gli proteins |
pid | nfat_3pathway | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
pid | p53regulationpathway | p53 pathway |
pid | ps1pathway | Presenilin action in Notch and Wnt signaling |
pid | wnt_noncanonical_pathway | Noncanonical Wnt signaling pathway |
kegg | hsa04310 | Wnt signaling pathway - Homo sapiens (human) |
kegg | hsa04340 | Hedgehog signaling pathway - Homo sapiens (human) |
kegg | hsa05165 | Human papillomavirus infection - Homo sapiens (human) |
kegg | hsa05224 | Breast cancer - Homo sapiens (human) |
kegg | hsa05225 | Hepatocellular carcinoma - Homo sapiens (human) |
kegg | hsa05226 | Gastric cancer - Homo sapiens (human) |
netpath | Pathway_Wnt | Wnt |
wikipathways | WP2583 | T-Cell Receptor and Co-stimulatory Signaling |
wikipathways | WP2806 | Human Complement System |
wikipathways | WP363 | Wnt Signaling Pathway |
wikipathways | WP3658 | Wnt-beta-catenin Signaling Pathway in Leukemia |
wikipathways | WP3664 | Regulation of Wnt-B-catenin Signaling by Small Molecule Compounds |
wikipathways | WP4216 | Chromosomal and microsatellite instability in colorectal cancer |
wikipathways | WP4249 | Hedgehog Signaling Pathway |
wikipathways | WP428 | Wnt Signaling Pathway |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-1643685 | Disease |
reactome | R-HSA-195253 | Degradation of beta-catenin by the destruction complex |
reactome | R-HSA-195721 | Signaling by WNT |
reactome | R-HSA-195721 | Signaling by WNT |
reactome | R-HSA-196299 | Beta-catenin phosphorylation cascade |
reactome | R-HSA-201681 | TCF dependent signaling in response to WNT |
reactome | R-HSA-201681 | TCF dependent signaling in response to WNT |
reactome | R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane |
reactome | R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane |
reactome | R-HSA-4791275 | Signaling by WNT in cancer |
reactome | R-HSA-4839735 | AXIN mutants destabilize the destruction complex, activating WNT signaling |
reactome | R-HSA-4839743 | phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex |
reactome | R-HSA-4839744 | truncated APC mutants destabilize the destruction complex |
reactome | R-HSA-4839748 | AMER1 mutants destabilize the destruction complex |
reactome | R-HSA-5339716 | Misspliced GSK3beta mutants stabilize beta-catenin |
reactome | R-HSA-5358351 | Signaling by Hedgehog |
reactome | R-HSA-5358351 | Signaling by Hedgehog |
reactome | R-HSA-5358747 | S33 mutants of beta-catenin aren't phosphorylated |
reactome | R-HSA-5358749 | S37 mutants of beta-catenin aren't phosphorylated |
reactome | R-HSA-5358751 | S45 mutants of beta-catenin aren't phosphorylated |
reactome | R-HSA-5358752 | T41 mutants of beta-catenin aren't phosphorylated |
reactome | R-HSA-5467337 | APC truncation mutants have impaired AXIN binding |
reactome | R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex |
reactome | R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex |
reactome | R-HSA-5610783 | Degradation of GLI2 by the proteasome |
reactome | R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome |
reactome | R-HSA-5610787 | Hedgehog 'off' state |
reactome | R-HSA-5610787 | Hedgehog 'off' state |
reactome | R-HSA-5632684 | Hedgehog 'on' state |
reactome | R-HSA-5632684 | Hedgehog 'on' state |
reactome | R-HSA-5635838 | Activation of SMO |
reactome | R-HSA-5635838 | Activation of SMO |
reactome | R-HSA-5663202 | Diseases of signal transduction |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD150 | RITA | 4 |
iGMDRD532 | Olaparib | 2 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 6 |
iGMDRD79 | Gemcitabine | 1 |
iGMDRD307 | Manumycin A | 5 |
iGMDRD330 | BRD4132 | 2 |
iGMDRD148 | Pifithrin-mu | 3 |
iGMDRD177 | Teniposide | 5 |
iGMDRD511 | CHEMBL399379 | 4 |
iGMDRD132 | (-)-gallocatechin-3-O-gallate | 2 |
iGMDRD85 | Ursolic acid | 3 |
iGMDRD499 | PDMP | 2 |
iGMDRD314 | Tanespimycin | 3 |
iGMDRD289 | Parthenolide | 4 |
iGMDRD221 | Tamoxifen | 2 |
iGMDRD415 | LE-135 | 2 |
iGMDRD77 | Itraconazole | 1 |
iGMDRD213 | SMR000068650 | 3 |
iGMDRD271 | Brefeldin A | 2 |
iGMDRD137 | Indisulam | 2 |
iGMDRD202 | Curcumin | 2 |
iGMDRD158 | NSC141540 | 5 |
iGMDRD246 | NPC26 | 2 |
iGMDRD82 | Quiflapon | 5 |
iGMDRD322 | FK 866 | 1 |
iGMDRD286 | Nsc 632839 | 2 |
iGMDRD871 | BRD6368 | 3 |
iGMDRD872 | BRD7137 | 4 |
iGMDRD427 | ABT737 | 9 |
iGMDRD494 | Neopeltolide | 2 |
iGMDRD554 | CHEMBL1434137 | 2 |
iGMDRD889 | Compound 7d-cis | 3 |
iGMDRD772 | BRD4770 | 2 |
iGMDRD425 | ERASTIN | 1 |
iGMDRD1008 | SR-II-138A | 5 |
iGMDRD394 | BX-795 | 2 |
iGMDRD280 | CYTOCHALASIN B | 3 |
iGMDRD634 | SCHEMBL2608041 | 3 |
iGMDRD375 | GW-405833 | 3 |
iGMDRD201 | SKI II | 4 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD171 | Pemetrexed | 3 |
iGMDRD318 | PAC-1 | 6 |
iGMDRD294 | Batimastat | 2 |
iGMDRD138 | PX 12 | 2 |
iGMDRD524 | ISX-9 | 6 |
iGMDRD577 | BIX01294 | 3 |
iGMDRD562 | Navitoclax | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CSNK1A1